Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul
Tampa-St. Petersburg news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg
Axios incorrectly reported on Tuesday that the Food and Drug Administration had signed off on a new and faster type of coronavirus test. We have removed that inaccurate story from our website.
What happened: A medical distribution company called Bodysphere said in a press release that the FDA had granted an “emergency use authorization” that could allow patients to get a diagnosis in only about two minutes.
- Axios reprinted that incorrect information, based on the press release.
- But the FDA confirmed Wednesday that it has not issued such an authorization. No two-minute diagnosis is available.
Axios' policy is to correct our mistakes and not to delete them.
- But because this story was premised entirely on the significance of an FDA action that didn't actually happen, and because diagnosing coronavirus is such an urgent and sensitive subject for so many people, we have removed this story in an effort to avoid causing any further confusion. We apologize for our mistake.